Thomas karikari, Researcher

New York, Dec 28 A group of neuroscientists has developed a test to detect a novel marker of Alzheimer's disease neurodegeneration in a blood sample.The biomarker, called "brain-derived tau" or BD-tau, outperforms current blood diagnostic tests used to detect Alzheimer's-related neurodegeneration clinically.It is specific to Alzheimer's disease and correlates well with Alzheimer's neurodegeneration biomarkers in the cerebrospinal fluid (CSF), according to the study led by a University of Pittsburgh School of Medicine researcher and published in the journal Brain."At present, diagnosing Alzheimer's disease requires neuroimaging," said senior author Thomas Karikari, assistant professor of psychiatry at Pitt."Those tests are expensive and take a long time to schedule, and a lot of patients don't have access to MRI and PET scanners. Accessibility is a major issue," he mentioned.To do that, they designed a special antibody that selectively binds to BD-tau, making it easily detectable in the blood.They validated their assay across over 600 patient samples from five independent cohorts, including those from patients whose Alzheimer's disease diagnosis was confirmed after their deaths, as well as from patients with memory deficiencies indicative of early-stage Alzheimer's.The tests showed that levels of BD-tau detected in blood samples of Alzheimer's disease patients using the new assay matched with levels of tau in the CSF and reliably distinguished Alzheimer's from other neurodegenerative diseases.Levels of BD-tau also correlated with the severity of amyloid plaques and tau tangles in the brain tissue confirmed via brain autopsy analyses.Scientists hope that monitoring blood levels of BD-tau could improve clinical trial design and facilitate screening and enrollment of patients from populations that historically haven't been included in research cohorts."The most important utility of blood biomarkers is to make people's lives better and to improve clinical confidence and risk prediction in Alzheimer's disease diagnosis," Karikari said.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Thomas KarikariFOLLOW

Thomas karikari, Latest News

Technology :New biomarker test can identify Alzheimer's neurodegeneration in blood: Study

A team of neuroscientists led by a University of Pittsburgh School of Medicine researcher developed a blood test to ... ...

Health :New test can detect Alzheimer's neurodegeneration in blood

New York, Dec 28 A group of neuroscientists has developed a test to detect a novel marker of ... ...